STIM
Medical Devices · Healthcare
Board Member
2020-07-14–present
Board Member
Neuronetics, Inc. (STIM)Equibles does not estimate personal net worth.
Get an email with a short summary when Neuronetics, Inc. publishes a filing, an earnings call transcript or a press release.
Get STIM alertsKeith J. Sullivan is recorded as Board Member at Neuronetics, Inc. (STIM) since July 14, 2020. Neuronetics, Inc. reported in an 8-K filed March 17, 2026 that Keith J. Sullivan retired as President and Chief Executive Officer, effective March 31, 2026. The proxy statement of Neuronetics, Inc. reports total compensation of $4,365,064 for Keith J. Sullivan in fiscal 2025, including a base salary of $728,000. Disclosed compensation is on record for 6 fiscal years. Keith J. Sullivan has spoken on 22 earnings calls across 1 company, most recently for Neuronetics, Inc. on March 17, 2026. Neuronetics, Inc. is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Neuronetics, Inc. includes Daniel L. Reuvers (CEO and Board Member), Daniel Reuvers (CEO), Robert A. Cascella (Chairman and Board Member) and 6 others.
“He succeeds Keith Sullivan, who will step down as the Company's President and Chief Executive Officer on March 23, 2026 and retire on March 31, 2026 after five and a half years of leading the Company.”
“Before I get into our results, I'm pleased to announce that the board has appointed Dan Reavers as our next president and chief executive officer of Neuronetics, effective March 23rd.”
“I'll begin by providing an overview of the third quarter performance and key operational updates.”
“I'll begin by providing an overview of our second quarter performance and our key operational updates. Steve Pfanstiel will then provide a brief introduction and review our financial results.”
“Let me start with our performance in the quarter, which represents our first full quarter inclusive of Greenbrook's financial results. Total revenue was $32 million, an increase of 84% over the first quarter of 2024.”
“I’ll begin by providing an overview of our recent performance, then discuss the status of the Greenbrook acquisition. Steve will then review our financial results and I’ll conclude with some thoughts on the balance of 2024 before turning to Q&A. Let me start with our performance in the quarter.”
2020-07-14–present
Start not stated–2026-03-31
STIM
Medical Devices · Healthcare
Board Member
2020-07-14–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Neuronetics, Inc. (STIM) | President and Chief Executive Officer | $728,000 | $4,365,064 |
| 2024 | Neuronetics, Inc. (STIM) | President and Chief Executive Officer | $728,000 | $2,430,610 |
| 2023 | Neuronetics, Inc. (STIM) | President and Chief Executive Officer | $700,000 | $2,990,985 |
| 2022 | Neuronetics, Inc. (STIM) | President and Chief Executive Officer | $676,000 | $2,452,214 |
| 2021 | Neuronetics, Inc. (STIM) | President and Chief Executive Officer | $650,000 | $2,838,730 |
| 2020 | Neuronetics, Inc. (STIM) | President and Chief Executive Officer | $279,615 | $3,566,068 |